RecruitingNCT07453381

Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In ANOCA/INOCA Patients: A Prospective, Multicenter, Single-Group Target Value Study


Sponsor

Peking University Third Hospital

Enrollment

114 participants

Start Date

Jun 30, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims to evaluate the sensitivity and specificity of a multi-sensor wireless pressure microcatheter for the diagnosis of CMD in patients with ANOCA/INOCA, using quantitative myocardial perfusion imaging of cardiac magnetic resonance (CMR) as a reference.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with coronary microvascular dysfunction (cmd). The study is currently recruiting participants at 5 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(5)

Wang Jing Hospital Of CACMS(China Academy of Chinese Medical Sciences)

Beijing, Beijing Municipality, China

Cangzhou Central Hospital

Cangzhou, Hebei, China

Chengdu Second People's Hospital

Chengdu, Sichuan, China

Beijing Anzhen Hospital.Capital Medical University

Beijing, China

Peking University Third Hospital

Beijing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07453381


Related Trials